Update: Personal Insurance Market SWOT Analysis by Leading Key Players: Allianz, AEGON, AIA Group

A new intelligence report released by HTF MI with title “Global Personal Insurance Market Survey & Outlook” is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Personal Insurance offers energetic visions to conclude market size, opportunities, growth pattern, and competitive surroundings. The research is derived through primary and secondary sourced data and includes both qualitative and quantitative detailing. Some of the key players profiled in the study are ACE Insurance, Achmea, AEGON, AIA Group, AlfaStrakhovanie, Allianz, Anadolu Hayat Emeklilik, Assicurazioni Generali, Assurant, Banamex, Banco Bilbao Vizcaya Argentaria, Banco Bradesco, BNP Paribas Cardif, China Life Insurance Company, China Pacific Insurance, CNP Assurances, Credit Agricole, DZ Bank, Garanti Emeklilik ve Hayat, Great Eastern Holdings, Grupo Nacional Provincial, Hanwha Life Insurance Company, HDFC Standard Life Insurance Company & ICICI Prudential Life Insurance Company.

What’s keeping ACE Insurance, Achmea, AEGON, AIA Group, AlfaStrakhovanie, Allianz, Anadolu Hayat Emeklilik, Market Overview of Personal Insurance
If you are involved in the Personal Insurance industry or aim to be, then this study is vital to keep your market knowledge up-to-date. The Market is segmented by Applications [Children, Aduts & Senior Citizens], Types / Coverage [, Life Insurance, Accident Insurance & Health Insurance] and major players. To get deep dive in market, geographically 22+ jurisdictions or countries were summarized in the study from Asia Pacific, MEA, South America, Europe and North America.


Assicurazioni Generali, Assurant, Banamex, Banco Bilbao Vizcaya Argentaria, Banco Bradesco, BNP Paribas Cardif, China Life Insurance Company, China Pacific Insurance, CNP Assurances, Credit Agricole, DZ Bank, Garanti Emeklilik ve Hayat, Great Eastern Holdings, Grupo Nacional Provincial, Hanwha Life Insurance Company, HDFC Standard Life Insurance Company & ICICI Prudential Life Insurance Company Ahead in the Market? Benchmark yourself with the strategic moves and findings recently released by HTF MI


Geographically, the global version of report has following country inclusion:
• North America [United States, Canada and Mexico]
• Europe [Germany, the UK, France, Italy, Netherlands, Belgium, Denmark, Spain, Sweden, and Rest of Europe]
• Asia-Pacific [China, Japan, South Korea, India, Australia, Indonesia and Others]
• South America [Brazil, Argentina, Colombia and Rest of South America]
• Middle East and Africa (South Africa, Turkey, Israel, GCC Countries and Rest of Africa)


This study mainly helps understand which market segments or Country; Insurance carriers, Aggregators should focus in years to come to channelize their efforts and investments in Personal Insurance to maximize growth and profitability. The growth in 2020 is noticeably slower and mature markets in North America and Western Europe requires “heavy lifting” to address such trends due to the dynamic macroeconomic and regulatory environment.

The distribution channels in the insurance industry, is always of great importance, reflecting the “push” nature of Personal Insurance offering in the industry. The distribution model has continued to evolve as insurers try to better connect with their customers. Over the years, the Personal Insurance industry has seen a clear dominance of face-to face selling (agents and brokers). However, with the increasing penetration of the Internet and customers preferring convenience, the digital mode of sales is becoming increasingly popular in Personal Insurance.

Furthermore, the years considered for the study are as follows:
Historical year – 2016-2020
Base year – 2020

Chapter One: Global Personal Insurance Market Industry Overview
1.1 Personal Insurance Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Personal Insurance Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Behaviour & Distribution Channels

Chapter Two: Global Personal Insurance Market Demand
2.1 Segment Overview
Children, Aduts & Senior Citizens

2.2 Global Personal Insurance Market Size by Application/End USers (2016-2020)
2.3 Global Personal Insurance Market Forecast by Application/End USers (2021-2026)

Chapter Three: Global Personal Insurance Market by Type
3.1 By Type
, Life Insurance, Accident Insurance & Health Insurance
3.2 Personal Insurance Market Size by Type (2016-2020)
3.3 Personal Insurance Market Forecast by Type (2021-2026)

Chapter Four: Personal Insurance Market: by Region/Country
4.1 Personal Insurance Market by Regions
4.2 Personal Insurance Market Revenue & share by Region
4.3 North America
4.4 Europe
4.5 Asia Pacific
4.6 South America
4.7 Middle East & Africa

Chapter Five: Player Analysis
5.1 Market Share Analysis by Players (2019-2021E)
5.2 Market Concentration Rate by Regions
5.3 Company Profiles


Thanks for reading Personal Insurance Industry research publication; you can also get individual chapter wise section or region wise report version like USA, China, Southeast Asia, LATAM, APAC etc.

Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
[email protected]

About Author:
HTF Market Intelligence consulting is uniquely positioned empower and inspire with research and consulting services to empower businesses with growth strategies, by offering services with extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist in decision making.



Remains a Serious Problem According to Action Against Hunger Poll for World Food Day

Action Against Hunger’s findings come on the heels of the 2021 Global Hunger Index, which found that hunger remains “serious, alarming, or extremely alarming in nearly 50 countries” and a United Nations report that 1 in 33 people globally need humanitarian assistance.

To mark World Food Day on October 16, Action Against Hunger, a nonprofit leader in the global movement to end hunger, today released the results of a survey of over 2,000 US adults conducted on their behalf by The Harris Poll showing that 86% of Americans believe global hunger remains a serious problem. An additional 73% of Americans say climate change will increase hunger among the world’s poorest communities, and more than half (56%) of respondents say richer countries, like the U.S., should help low-income countries pay for the costs of adapting to climate change.
Photo: Cyril Zannattacci / Agence VU’ for Action Against Hunger, Kenya (PRNewsfoto/Action Against Hunger)
Photo: Cyril Zannattacci / Agence VU’ for Action Against Hunger, Kenya (PRNewsfoto/Action Against Hunger)

“The vast majority of Americans recognize that global hunger is a serious problem, and that the climate crisis is a hunger crisis. Now, our leaders must step up to act on our concern,” said Dr. Charles Owubah, CEO, Action Against Hunger. “Around the world, 811 million people go to bed hungry every night — and in too many parts of the world, hunger can be deadly. We must make every day World Food Day until we achieve our mission of ending hunger for everyone, for good.”

Additional survey findings include:

Nearly half of all Americans worry about increases in food prices as a result of climate change. In addition, 46% of Americans said that among their greatest climate worries for the next generation is “living in a world with less food (i.e., more food scarcity because of climate shocks).”
Boomers are most likely to say that global hunger remains a serious problem. Awareness of global hunger as a serious issue is statistically significant among Boomers (ages 57-75) who are more likely than Gen Z (ages 18-24) and Gen X (ages 41-56) to believe global hunger is still a serious issue in the world today (89% vs. 81% and 83%).
75% of Americans think climate change poses a threat to the future of the human race, and 74% believe we all – including groups like government, nonprofits, and business – should do more to tackle climate change. A similar study from Action Against Hunger UK found similar concerns among the public there.
60% of men, 68% of Gen Z, and 76% of Black Americans believe that richer countries, like the U.S., should help low-income countries pay for the costs of adapting to climate change. Among men, 60% agree with this approach, as compared with 53% of women. 76% of non-Hispanic Black Americans agree with this sentiment, as compared to just 50% of non-Hispanic White Americans and 61% of Hispanic Americans. 68% of Gen Z and 65% of Millennials agree, as just 52% of Gen X and 47% of Boomers.


“Awareness if an important first step. Now, the world needs more effective and accountable ways to address hunger and climate change as growing public health threats,” Dr. Owubah said. “A failure to address hunger can be deeply destabilizing to already-fragile states, since hunger is both a cause and effect of conflict. When we invest in fighting hunger and saving lives, we invest in the future: research has shown that every $1 spent combating malnutrition deliver as much as a $16 return to society.”

Survey Method
This survey was conducted online within the United States by The Harris Poll on behalf of Action Against Hunger between October12-14, 2021 among 2,019 US adults ages 18+. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables and subgroup sample sizes, please contact Shayna Samuels, 718-541-4785 or

Action Against Hunger




Medicine revisa y publica datos de fase II de la vacuna Medigen COVID-19

The Lancet Respiratory Medicine, una de las revistas médicas revisadas por pares más conocidas del mundo, ha publicado datos de Medigen Vaccine Biologics (MVC) de su ensayo clínico de fase 2 de la vacuna MVC-COV1901 que demuestra perfiles de inmunogenicidad y seguridad prometedores. La fuente internacionalmente fiable de conocimiento clínico, público y de salud global ha puesto a disposición los resultados de un ensayo de fase 2 a gran escala, doble ciego, aleatorizado y controlado con placebo realizado en once sitios en Taiwán, haciendo que MVC sea visible para una red global de investigadores, médicos, líderes de la industria y otros profesionales en el campo.

El estudio, que se llevó a cabo entre el 30 de diciembre de 2020 y el 2 de abril de 2021, vio a 3.854 individuos seleccionados y asignados al azar (6:1) al grupo MVC-COV1901 o al grupo placebo. Los participantes elegibles eran adultos sanos de 20 años o más. A los participantes se les administraron por vía intramuscular dos dosis de MVC-COV1901 o placebo con 28 días de diferencia.

Los resultados presentados indicaron que la tasa de seroconversión, basada en el SARS-CoV-2 GMT de tipo salvaje, en el grupo MVC-COV1901 el día 57 fue del 99 • 8%. Tanto en adultos jóvenes como en adultos mayores que recibieron la vacuna MVC-COV1901, casi todos los participantes tuvieron seroconversión en adultos jóvenes y 99 • 5% en adultos mayores.

El diseño del antígeno SARS-CoV-2 utilizado en la vacuna MVC-COV1901 fue autorizado por los NIH de EE. UU., Lo que implica una variedad de modificaciones moleculares de la proteína de pico de fusión previa S-2P. La combinación de CpG 1018 e hidróxido de aluminio con esta proteína de pico de fusión previa S-2P muestra una provocación prometedora de la inmunidad tanto de células T como de células B. Uno de los hallazgos más distintivos en el perfil de seguridad es la incidencia extremadamente baja de fiebre.

En conclusión, el análisis intermedio mostró que la vacuna MVC-COV1901 tiene un buen perfil de seguridad y genera títulos de anticuerpos neutralizantes prometedores. En comparación con otras vacunas que han recibido autorización de uso de emergencia, MVC-COV1901 es segura, bien tolerada y rara vez causa reacciones febriles tanto en adultos jóvenes como en adultos mayores. MVC-COV1901 induce títulos altos de anticuerpos neutralizantes y de IgG anti-pico, y tiene una tasa de seroconversión de casi el 100% para el día 57. Utilizando los modelos de conversión de IU y BAU de la OMS, ambos métodos utilizados en el documento proporcionan una eficacia predictiva que oscila entre el 80 y el 90%.

Los resultados del estudio sirvieron como base para el inmunobridamiento que otorga la autorización de uso de emergencia de la vacuna MVC-COV1901 en Taiwán y puede respaldar el avance en desarrollos posteriores.

Acerca de Medigen Vaccine Biologics Corp. (MVC)

MVC es una empresa biofarmacéutica que utiliza tecnologías basadas en células para desarrollar nuevas vacunas y biosimilares. Con el objetivo de la autosuficiencia nacional, MVC también tiene como objetivo proporcionar vacunas y productos biofarmacéuticos para satisfacer las necesidades regionales y con el deseo de ayudar a nivel mundial contra las amenazas de las enfermedades infecciosas. La cartera de MVC incluye la vacuna contra el enterovirus A71, la vacuna contra el dengue y la vacuna tetravalente contra la gripe, todas las cuales han entrado en una etapa clínica tardía. La instalación de producción a gran escala de MVC es de vanguardia y cumple con los requisitos internacionales de GMP de PIC/s. Para obtener más información, visite

Contacto de Medigen:




Participate in World Vaccine Congress Europe

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Vivek Shinde, M.D., Vice President, Clinical Development, will deliver a presentation during the World Vaccine Congress Europe 2021. A topic of discussion will be Novavax’ COVID-NanoFlu™ Combination Vaccine, which combines the company’s recombinant nanoparticle protein-based COVID-19 and NanoFlu™ vaccine candidates with Matrix-M™ adjuvant in a single formulation.

Session details are as follows:


Wednesday, October 20, 2021


11:30 a.m. – 12:00 p.m. Central European Time (CET) /
5:30 a.m. – 6:00 a.m. Eastern Daylight Time (EDT)


Update on Novavax’ NanoFlu vaccine and COVID-19-NanoFlu Combination Vaccine development

Novavax Participant:

Vivek Shinde, M.D., Vice President, Clinical Development

For more information or to register, visit the Congress website.

About Novavax
Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company’s proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs. Novavax is conducting late-stage clinical trials for NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID-19. NanoFlu™, its quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Phase 3 clinical trial in older adults. Both vaccine candidates incorporate Novavax’ proprietary saponin-based Matrix-M™ adjuvant to enhance the immune response and stimulate high levels of neutralizing antibodies.

For more information, visit   and connect with us on Twitter and LinkedIn.





Oppenheimer & Co. as underwriter in PepperLime Health Acquisition Corporation’s US$150 million IPO

DLA Piper represented Oppenheimer & Co. Inc. as underwriter in PepperLime Health Acquisition Corporation’s initial public offering of 15,000,000 units at a price of $10.00 per unit.

PepperLime is a special purpose acquisition company (SPAC) that will focus on companies at the intersection of technology and consumer health and wellness.

“We appreciated the opportunity to leverage our market-leading experience advising underwriters in complex capital markets transactions, as well as our technology and healthcare sector capabilities, to help Oppenheimer deliver this transaction for PepperLime,” said Curtis Mo, the DLA Piper partner who led the firm’s deal team.

In addition to Mo (Silicon Valley), the DLA Piper team included partner Christine Lehr (Raleigh) and associates Elena Nrtina (San Francisco), Annie Letizia (Silicon Valley) and Melissa Lucar (San Diego).

DLA Piper’s global capital markets team represents issuers and underwriters in registered and unregistered equity, equity-linked and debt capital markets transactions, including initial public offerings, follow-on equity offerings, equity-linked securities offerings, and offerings of investments grade and high-yield debt securities. DLA Piper also represented Tristar Acquisition I Corp. in its US$200 million IPO this week.

DLA Piper’s global Technology sector lawyers work across practice areas and offices to support technology clients – from startups to fast-growing and mid-market businesses to mature global enterprises – doing business around the world.

About DLA Piper




COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted 19-0 to recommend Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following initial vaccination with the single-shot vaccine.

The vote was based on findings from two Company clinical trials, including the Phase 3 ENSEMBLE 2 study, which evaluated a booster dose of the Johnson & Johnson COVID-19 vaccine administered two months after the single-shot, as well as a large and robust real-world evidence study. The Company also presented data that support the increased potential of a booster when administered at six months. Phase 3 clinical data and real-world data both demonstrated the Johnson & Johnson single-shot COVID-19 vaccine was strong and long-lasting.

“Today’s recommendation is based on the totality of evidence, with clinical and real-world data showing that while a single shot offers strong and long-lasting protection against COVID-19, a booster given after the single-dose primary vaccination increases protection, in particular against symptomatic COVID-19,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson.

“Johnson & Johnson is steadfast in its commitment to protect as many people globally as possible against the continued spread of COVID-19,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, Johnson & Johnson. “Today’s recommendation by the VRBPAC is another step toward ensuring that those who have received the single-shot Johnson & Johnson vaccine – or will receive it in the future – are provided the opportunity to increase their protection against COVID-19. We look forward to sharing these data with regulatory bodies and advisory groups around the world to address the continued threat of COVID-19.”

The Company’s EUA amendment submission included results from the Phase 3 ENSEMBLE 2 study, which found a booster dose at two months provided 94 percent protection against symptomatic (moderate to severe/critical) COVID-19 in the United States (CI, 58%-100%) and 100 percent protection (CI, 33%-100%) against severe/critical COVID-19, at least 14 days post-booster vaccination. Also submitted were findings from a Phase 1/2a study evaluating a booster dose given six months after the first shot, which show antibody levels increased nine-fold one week after the booster, and continued to climb to 12-fold higher four weeks after the booster.

The vaccine, when given as a booster or primary dose, was generally well-tolerated, with no new safety signals observed in the two-dose ENSEMBLE 2 trial compared with single-dose studies.

The submission also included data from a large and robust U.S. real-world evidence study, conducted from March to July 31, 2021, and recently extended to August 31, 2021. These real-world data demonstrated the single-dose Johnson & Johnson COVID-19 vaccine showed stable vaccine effectiveness of 76 percent (CI, 75%-77%) for COVID-19-related infections and 81 percent (CI, 79%-84%) for COVID-19-related hospitalizations, with no evidence of reduced effectiveness over the study duration of six months – including when the Delta variant became dominant in the U.S. (sequencing data were not available for analysis).

Johnson & Johnson remains committed to helping end this pandemic as quickly as possible and is committed to diligently generating and evaluating real-world evidence, as well as evidence from its ongoing clinical trial program.

The Company anticipates a decision from the FDA on the EUA amendment for a booster dose of the Johnson & Johnson COVID-19 vaccine in the coming days, and plans to submit relevant data to other regulators, the World Health Organization (WHO) and National Immunization Technical Advisory Groups (NITAGs) worldwide to inform decision-making on local vaccine administration strategies, as needed. The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) will discuss the use of boosters and provide a potential recommendation on October 21.

In the U.S., there is sufficient supply to support boosting to those who have received the more than 15.1 million doses of the Johnson & Johnson COVID-19 vaccine that have been administered as primary vaccinations.

The Johnson & Johnson single-shot COVID-19 vaccine, developed by its Janssen Pharmaceutical Companies of Johnson & Johnson, received initial EUA in the United States on February 27, 2021 and Conditional Marketing Authorization (CMA) by the European Commission on March 11. The World Health Organization (WHO) issued Emergency Use Listing on March 12, and the Company received an interim recommendation by the Strategic Advisory Group of Experts (SAGE) on Immunization for the WHO on March 17. Many more authorizations have been granted in countries worldwide, and regulatory submissions are ongoing.




World NATION/WORLD BRIEFS Oct. 16, 2021 | Local News

Invoice Clinton in hospital for non-COVID-19-related an infection

WASHINGTON — Former President Invoice Clinton was admitted to a Southern California hospital with an an infection however is “on the mend,” his spokesman stated.

Clinton, 75, was admitted to the College of California Irvine Medical Heart on Tuesday night for a non-COVID-19-related an infection, Angel Ureña stated Thursday in a press release.

“He’s on the mend, in good spirits and is extremely grateful to the medical doctors, nurses, and workers offering him with wonderful care,” Ureña stated.

A second assertion from Clinton’s spokesman quoted physicians Dr. Alpesh Amin and Dr. Lisa Bardack, who stated the previous president has been “administered IV antibiotics and fluids.”
Legal professional: Cruz to plead responsible to Parkland college bloodbath

FORT LAUDERDALE, Fla. — The gunman who killed 14 college students and three workers members at a Parkland, Florida, highschool will plead responsible to their murders, his attorneys stated Friday, bringing some closure to a South Florida group greater than three years after an assault that sparked a nationwide motion for gun management.

The responsible plea would arrange a penalty part the place Nikolas Cruz, 23, could be preventing towards the dying penalty and hoping for all times with out parole.

Cruz legal professional David Wheeler instructed Circuit Decide Elizabeth Scherer that he’ll plead responsible Wednesday to 17 counts of first-degree homicide within the February 2018 taking pictures at Marjory Stoneman Douglas Excessive Faculty. The pleas will include no situations and prosecutors nonetheless plan to hunt the dying penalty. That might be determined by a jury, with the choose hoping to start out the trial in January after selecting a jury from hundreds of prospects beginning in November.

Cruz may even plead responsible to 17 counts of tried first-degree homicide. He was not initially current through the listening to, however later entered the Broward County courtroom to plead responsible to attacking a jail guard 9 months after the taking pictures.
Suicide assault on Shiite mosque in Afghanistan kills 47

KABUL, Afghanistan — Suicide bombers attacked a Shiite mosque full of worshippers attending Friday prayers in southern Afghanistan, killing a minimum of 47 folks and wounding 70, a Taliban official stated. It was the deadliest day for the reason that U.S. army withdrawal.

There was no quick declare of accountability for the carnage on the Fatimiya mosque in Kandahar province. The assault got here per week after a bombing claimed by the native Islamic State affiliate killed 46 folks at a Shiite mosque in northern Afghanistan.

The sectarian bloodletting has raised fears that IS — an enemy of each the Taliban and the West — is increasing its foothold in Afghanistan.
China launches three astronauts on 6-month house station mission

BEIJING — China on Saturday launched a three-person crew for a six-month mission aboard its house station that’s deliberate at setting a brand new report for the size of time spent in house by Chinese language astronauts because the nation strikes towards finishing the orbiting construction.

The Shenzhou-13 spaceship carrying the three astronauts was launched by a Lengthy March-2F rocket at 12:25 a.m. Saturday (4225 GMT Friday).

It’s anticipated to finish docking with the Tianhe module inside the subsequent six hours, starting the mission that may proceed the work of the primary three-person crew that spent 90 days aboard. These crew members carried out two spacewalks and deployed a 10-meter (33-foot) mechanical arm earlier than returning to Earth in mid-September.
Israel quietly advances settlements with little US pushback

JERUSALEM — Israel is quietly advancing controversial settlement initiatives in and round Jerusalem with out making main bulletins that might anger the Biden administration. Critics say the newest strikes, whereas incremental, pave the way in which for fast progress as soon as the political local weather adjustments.

On Wednesday, as International Minister Yair Lapid met with U.S. officers in Washington, an area planning committee in Jerusalem accredited the expropriation of public land for the particularly controversial Givat Hamatos settlement, which might largely reduce town off from Palestinian communities within the southern West Financial institution.

The identical committee superior plans for the development of 470 properties within the present east Jerusalem settlement of Pisgat Zeev. Authorities have scheduled a Dec. 6 listening to for an additional venture in east Jerusalem to construct 9,000 settler properties within the Atarot space, based on Ir Amim, an Israeli rights group that carefully follows developments within the metropolis.



Inaugural 5KforJK Event Which Raises More than $93,000 for Parkinson’s Research

It started out as a small idea with a few friends. When Jessica Krauser, now 39, was diagnosed with Young Onset Parkinson’s Disease at 37 her friends wanted to do something to help. “We really just wanted to provide a platform for her to tell her story,” explains Melissa Carlson, Founder and Owner of pDNextSteps in Dublin, Ohio. pDNextSteps is a gym dedicated to helping Parkinson’s patients. Jessica met Melissa when a friend suggested the benefits of exercise to slow the progression of the disease.

The 5KforJK was the first of an annual 5K walk in Powell Ohio on Sunday, October 3rd. More than 500 people attended and raised over $93,000 for The Michael J. Fox Foundation for Parkinson’s Research and local efforts. “We want to promote local awareness, create support groups and help the local Parkinson’s community,” explains Jessica Krauser. Local organizations stepped in to help, including Mix Talent, a national life science recruiting and consulting firm. “We want to support organizations like this who are bringing awareness and education to diseases like Parkinsons,” explains K.C. McAllister, Principal, Head of Strategy with Mix Talent.

“I know we will one day find a cure and want to do my part in making it possible,” states Krauser.

For more information on getting involved or donating go to

SOURCE Mix Talent
Related Links





Update: Nuubu Detox Patches™ New Zealand – NZ – ’30 Pads NZD 65.3 + Shipping’ [Shop Now] STOP SMOKING 2021?

Nuubu Detox Patches NZ Reviews: Nuubu Detox Patches is the progressive detox fix that can flush out the hurtful synthetic substances and toxins from the human system. You need to apply the patches to the foot. It works most of the night adequately to eliminate weighty metals, metabolic squander, toxins, and unsafe synthetic substances from the body. It eliminates all destructive substances from the framework to give you an appropriately working body. It further develops rest quality and decreases weariness levels brought about by unsafe toxins in the body.


Nuubu Detox Patch additionally further develops invulnerability and brings down pulse while calming muscle agony and joint torment. The fix additionally centers around expanding blood flow and advancing general prosperity. The fix is more beneficial for individuals who experience the ill effects of clogging and keeps the body from being presented to radiation. It likewise eliminates overabundance dampness from the body.

Searching For Nuubu Detox Foot Patches in New Zealand?

There are numerous positive Nuubu detox patches reviews from clients in NZ who are glad clients of these detox foot pads.

You can buy Nuubu detox foot patches in NZ straightforwardly from the producer’s site, with conveyance choices accessible throughout New Zealand. Nuubu detox patches are a 100% natural way of detoxifying the collected toxins from your body. These foot patches are becoming well known worldwide, and presently Nuubu is accessible to arrange in NZ!


Nuubu Detox Patches NZ Reviews 2021 – What does it Do?

People are continually presented to contaminations and natural substances, which over-burdens the framework with different kinds of toxins and unsafe synthetics. Flush these toxins out of the framework to carry on with a reliable way of life. It is the place where the Nuubu Detox Patch acts as the hero. It is an incredible detoxification fix and the best option in contrast to the conventional detoxification treatment.

It is the detoxification fix that can flush out the destructive materials and toxins from the body. It works viably without making any incidental effects on your framework. You need to apply the fix on foot, and it assists with eliminating toxins, substantial metals, metabolic squanders, and other destructive synthetic compounds from the body.

How does the Nuubu Detox Patch work?

Nuubu Detox Patch should be applied to the foot during rest. The fix should be used for eight hours every day around evening time, and it attempts to wipe out considerations and toxins development from the body. The fix utilizes the extraordinary reusing technique and flushes out the unsafe substances and synthetics from the framework. It eliminates toxins development, ad-libs the overall prosperity, and assists you with improving your working body and soul. The errand of the fix is to extricate hurtful synthetic compounds and slight dampness from the body, and it turns out ceaselessly for eight hours to show results.

Nuubu Detox Patch is intended to work viably to eliminate toxins from the body while further developing insusceptibility and the side effects of stoppage. In addition, it advances a better course of blood through the body and permits you to have a better body and soul.


What is the Nuubu Detox Patches NZ Price?

The Nuubu Detox cost is in USD; at the hour of this composition, the approximate NZD cost is additionally recorded.

1 Box (10 pads) = $17.95 USD – around 25.51 NZD

2 Boxes (20 pads) = $33.96 USD – around 48.25 NZD

3 Boxes (30 pads) = $45.96 USD – around 65.30 NZD

4 Boxes (40 pads) = $55.96 USD – around 79.50 NZD

Nuubu Detox Patches Benefits

The “Nuubu Detox” patches for the feet depend on information on customary Japanese medication. However, they are harmless to the ecosystem and are an all-natural technique for eliminating destructive toxins gathered over the long haul by the body to develop wellbeing further.

We have arranged here the principle benefits set forward by the producer:

– Eliminates toxins aggregated in the body!

– Holistic methodology from Japan!

– Improves actual wellbeing!

– Improves psychological wellbeing!

– Natural ingredients!

– Easy to utilize!


Nuubu Detox Patches NZ – Reviews From Real Customers

“I genuinely didn’t anticipate a lot of alleviation for my hurting feet. But, kid, was I off-base! I generally prefer not to hit the hay since I have cramps in my legs and toes in the evening. After I put the foot patches on, I felt a shivering sensation in my feet. Like a spasm was coming. It before long died down, and I had perhaps the greatest night I can recall. I will arrange them again soon!”

“I have been utilizing these foot patches once every week for the beyond two months. I truly feel like they detox every one of the contaminations from my feet, increment my energy, work on my rest, and for the most part, cause me to feel fitter. I really accept that the feet are the way to general body health. The foot patches are extraordinarily simple to utilize. I will keep on utilizing them.”

For what reason Do I require Nuubu Detox Patches?

Essentially, every individual potentially ingests a few toxins the entire life, such as through food, hair, healthy skin items, breathing air, or drinking water. A portion of these toxins can develop in the body and mess some up there. As indicated by the provider of the Nuubu patches, aggregations of toxins can prompt helpless focus, skin issues, personal stench, weariness, migraines, obstinate weight, muscle issues, touchiness, and a sleeping disorder, for instance.

As indicated by the supplier, these side effects brought about by toxins ought to likewise vanish again, specifically when the toxins vanish from the body. Nuubu patches are said to help by shipping toxins through the reflex focuses on the foot to the external dependent on ancient Asian information. This should lead the side-effects of the digestion just like the toxins to the outside and mitigate the grievances brought about by the substances


World North Korea Accepts Covid Supplies, and Other World News

The World Well being Group mentioned on Thursday that it had resumed shipments of medical provides to North Korea to assist its Covid-19 response, in what seems to sign a leisure of the closed-border insurance policies enforced by Pyongyang early within the pandemic.

The company mentioned its shipments of medical provides, along with different worldwide provides destined for North Korea, had grow to be stranded in China after Pyongyang sealed the nation’s borders in January 2020 when Covid-19 was declared a public well being emergency of worldwide concern.

North Korea’s Ministry of Public Well being instructed the company a number of months in the past that it could enable the stranded provides to be transported via the northern Chinese language port of Dalian, a W.H.O. spokesman, Tarik Jasarevic, mentioned in an emailed assertion.

Consequently, the company had despatched a number of the medical provides and gear to the North Korean port of Nampo, he mentioned.

The W.H.O. mentioned its shipments to North Korea included well being kits, medicines and different medical provides that might help important well being companies at main well being care facilities.

The company mentioned it had been instructed that these provides remained below quarantine in Nampo.

In different information from all over the world:

The authorities in France introduced that, as of Oct. 15, coronavirus screening assessments would not be free for unvaccinated individuals, signaling a brand new part within the authorities’s technique to encourage inoculations. The change signifies that unvaccinated individuals will bear the monetary burden of assembly the proof of coronavirus standing required by a legislation enacted this summer time earlier than they will enter cafes, eating places, theaters and plenty of different indoor venues.

The 14-day common of recent day by day coronavirus instances in Spain dropped beneath 50 per 100,000 individuals on Thursday for the primary time in additional than a yr, Reuters reported. Prime Minister Pedro Sánchez known as the return to low-risk standing “an important milestone on the highway to restoration” on Twitter.

Beginning on Saturday, Greece will start a two-week check of lifting some pandemic restrictions in areas the place coronavirus instances have been the very best, however for essentially the most half, solely vaccinated individuals will be capable to benefit from the heightened freedom. The restrictions — notably a curfew from 1 a.m. to six a.m. and a ban on music in bars and eating places — have been imposed final month in “purple areas” throughout a lot of the nation’s north and components of its heart, as a option to struggle a fourth wave of the virus. However unvaccinated individuals who can not show that they just lately recovered from Covid stay barred from indoor venues like bars, cafes and eating places.

Whilst mother and father in the US wrestle with tough questions over vaccinating their youngsters towards the coronavirus, households in different international locations have been supplied a novel possibility: giving youngsters only one dose of the vaccine. Officers in Britain, Hong Kong, Norway and different international locations have really useful a single dose of the Pfizer-BioNTech vaccine for youngsters ages 12 and older — offering partial safety from the virus, however with out the potential harms sometimes noticed after two doses. On Wednesday, Sweden and Denmark introduced that adolescents ought to get just one jab of the Moderna vaccine.

The British authorities mentioned Thursday that worldwide journey restrictions will probably be additional relaxed subsequent week by eradicating the resort quarantine requirement for arrivals to England from 47 international locations, together with South Africa, Mexico and Thailand. The change comes into impact on Monday, and solely seven international locations will stay on the “purple checklist” of holiday makers required to to enter resort quarantine for 11 nights.

New figures by the Robert Koch Institute present that Germany has vaccinated 3.5 million extra individuals towards the coronavirus than beforehand thought. The nation’s well being minister mentioned Thursday that some vaccinations, notably of staff at massive corporations or these given by cell vaccination groups, could haven’t been absolutely reported.